Evaluation of immunogenicity and tolerance of single dose haemophilus influenzae type B (PRP-T) vaccine.
Indian Pediatr
;
1995 Oct; 32(10): 1077-82
Artículo
en Inglés
| IMSEAR
| ID: sea-11646
ABSTRACT
OBJECTIVE:
Evaluation of immunogenicity and acceptability of PRP-T vaccine among the Indian children.DESIGN:
Multicentric, open, parallel group, comparative study of Haemophilus influenzae type B vaccine, given as single (Group I) or associated (Group II) with DPT vaccine.SETTING:
Five different vaccination clinics.SUBJECTS:
125 children between the age group of 18-24 months. PARAMETERS Measurement of (i) pre and post vaccination antibody titres of Haemophilus influenze type B specific antibody; (ii) Adverse events; and (iii) Tolerance as graded by the physician.RESULTS:
Prevaccination antibody levels were > 0.15 mcg/ml in 56.3% in Group I and 35.7% in Group II. Post-seroconversion was seen in 97% in Group II receiving single and all in Group II (P > 0.05). The vaccine was well tolerated.CONCLUSIONS:
The probability of subclinical infection or cross immunity is high in India. ACTHIB vaccine has a good immunogenicity and tolerance and association with DPT does not modify the immunogenicity of ACTHIB vaccine.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Femenino
/
Humanos
/
Masculino
/
Haemophilus influenzae
/
Vacunación
/
Vacunas contra Haemophilus
/
Países en Desarrollo
/
Estudios de Evaluación como Asunto
/
Infecciones por Haemophilus
/
India
Tipo de estudio:
Ensayo Clínico Controlado
/
Estudio diagnóstico
/
Estudios de evaluación
País/Región como asunto:
Asia
Idioma:
Inglés
Revista:
Indian Pediatr
Año:
1995
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS